Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dopamine Activity”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Testing effectiveness (Phase 2)Study completedNCT00592943
What this trial is testing

PET Study Examining the Dopaminergic Activity of Armodafinil in Adults

Who this might be right for
Healthy
Massachusetts General Hospital 12
Not applicableUnknownNCT03515668
What this trial is testing

Dopamine and Muscle Function in the Heat

Who this might be right for
Muscle ForceHyperthermia
Brock University 6
Post-approval studies (Phase 4)UnknownNCT06171087
What this trial is testing

Emotions, Dopamine, Brain and Body

Who this might be right for
Emotions
German Institute of Human Nutrition 40
Very early researchEnded earlyNCT02393027
What this trial is testing

Quantification of Dopamine Active Transporter (DAT) in Humans: Validation of a New Radiophamaceutical, the [18F] LBT-999

Who this might be right for
Idiopathic Parkinson Disease
University Hospital, Tours 16
Testing effectiveness (Phase 2)Study completedNCT00942253
What this trial is testing

Exercise Training in Dialysis Patients With Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs SyndromeEnd Stage Renal DiseaseHemodialysis+2 more
University of Thessaly 46
Post-approval studies (Phase 4)Study completedNCT00145132
What this trial is testing

Beta-CIT-SPECT and Neurophysiology in Depression

Who this might be right for
Depression
Ludwig-Maximilians - University of Munich 30
Early research (Phase 1)Study completedNCT01065558
What this trial is testing

Safety and Tolerability of the D1 Dopamine Receptor Antagonist Ecopipam in Patients With Lesch-Nyhan Disease

Who this might be right for
Lesch-Nyhan Disease
Psyadon Pharma 5
Testing effectiveness (Phase 2)Ended earlyNCT01264861
What this trial is testing

Evaluate Safinamide's Effect on Dopamine and Serotonin's Availability by Using Brain Imaging

Who this might be right for
Parkinson Disease
Newron Pharmaceuticals SPA 5
Large-scale testing (Phase 3)Study completedNCT00367822
What this trial is testing

Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)

Who this might be right for
Restless Legs Syndrome
Axxonis Pharma AG 300
Not applicableStudy completedNCT01218425
What this trial is testing

Dopaminergic Modulation of Cognition and Psychomotor Function

Who this might be right for
Dopamine ActivityEpisodic Memory ConsolidationResponse Preparation
Maastricht University Medical Center 20
Not applicableLooking for participantsNCT06387732
What this trial is testing

Mechanisms Underlying Antidepressant Effects of Physical Activity

Who this might be right for
Depression
University College, London 250
Large-scale testing (Phase 3)Study completedNCT01104766
What this trial is testing

Safety and Efficacy of Cariprazine in Patients With Schizophrenia

Who this might be right for
Schizophrenia
Forest Laboratories 617
Early research (Phase 1)Study completedNCT01045083
What this trial is testing

The Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers

Who this might be right for
Healthy Volunteer
Hoffmann-La Roche 25
Post-approval studies (Phase 4)Looking for participantsNCT06223880
What this trial is testing

Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms

Who this might be right for
Major Depressive Disorder
Axsome Therapeutics, Inc. 350
Very early researchStudy completedNCT03709667
What this trial is testing

Exercise in Methamphetamine Use Disorder Upregulation and Neural Function

Who this might be right for
Methamphetamine Abuse
University of California, Los Angeles 113
Large-scale testing (Phase 3)Not Yet RecruitingNCT07238465
What this trial is testing

Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome

Who this might be right for
Down SyndromeAutonomic Dysfunction
University of Colorado, Denver 200
Post-approval studies (Phase 4)Looking for participantsNCT07045935
What this trial is testing

Metabolic Outcomes in Patients With Prolactinomas Under Dopamine Agonist Treatment

Who this might be right for
Prolactinoma
University Hospital, Basel, Switzerland 60
Not applicableStudy completedNCT02118610
What this trial is testing

Treatment of Schizophrenia With L-tetrahydropalmatine (l-THP): a Novel Dopamine Antagonist With Anti-inflammatory and Antiprotozoal Activity

Who this might be right for
Schizophrenia
University of Maryland, Baltimore 63
Post-approval studies (Phase 4)Study completedNCT01278342
What this trial is testing

Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients

Who this might be right for
Acromegaly
Novartis Pharmaceuticals 70
Testing effectiveness (Phase 2)WithdrawnNCT05103618
What this trial is testing

Effect of Meditation and Controls and Subjects With Parkinson's Disease on Brain Activity Measured by fMRI With FDOPA

Who this might be right for
Parkinson DiseaseIdiopathic Parkinson Disease
Andrew Newberg
Load More Results